A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years
B. Thjodleifsson, G. Rindi, R. Fiocca, T. J. Humphries, A. Morocutti, N. Miller, K. D. Bardhan, FOR THE EUROPEAN RABEPRAZOLE STUDY GROUPVolume:
17
Year:
2003
Language:
english
Pages:
9
DOI:
10.1046/j.1365-2036.2003.01446.x
File:
PDF, 101 KB
english, 2003